Status:
RECRUITING
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Genome Canada
Genome British Columbia
Conditions:
Adverse Drug Reaction (ADR)
Eligibility:
All Genders
Brief Summary
The purpose of the study is (1) to identify and collect samples from children and adults who take drugs and have adverse drug reactions AND children and adults who take drugs and do not experience any...
Detailed Description
CPNDS will identify ADR predictive markers by comparing DNA and plasma samples from patients that suffer ADRs with samples from control populations that are stratified by medication type and age. The ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Children under 19 years who have taken drugs.
- Biological parents of children who have had an ADR.
- Patients/parents who speak and understand English (except in Quebec).
- Adults (for validation of findings in children)
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2029
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT00414115
Start Date
August 1 2005
End Date
March 1 2029
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's and Women's Health Centre of British Columbia
Vancouver, British Columbia, Canada, V6H 3V4